Logo
Search
The Procurement Brief
LOG IN
SIGN UP
HOME
ARCHIVE

Contract Pharmacy

Manufacturer restrictions, state legislation, and pharmacy distribution changes.

340B

+5

Lilly Warning Letters Put 340B Pricing Access at Risk

May 19, 2026

•

2 min read

Lilly Warning Letters Put 340B Pricing Access at Risk

The rebate model is not dead. Here is what your compliance team needs to do this week.

Alex Ndanga
Alex Ndanga

The Procurement Brief

Hospital supply chain news, GPO contracts, and 340B updates for procurement directors at acute care hospitals and IDNs.

© 2026 The Procurement Brief.
Report abusePrivacy policyTerms of use
beehiivPowered by beehiiv